Continuing GLP-1/GIP agonist therapy prior to elective upper endoscopy increases the risk for residual gastric volume, but ...

Patients on GLP-1 or GLP-1/GIP agonists had significant residual gastric volume if the medication was not held prior to upper endoscopy, unless they were on a clear liquid diet the previous day, ...

Residual gastric volume precluded endoscopic examination ...

A recent study published in the Journal of the American Medical Association found that patients taking glucagon-like peptide-1 (GLP-1) or glucose-dependent insulinotropic polypeptide (GIP) ...

Worldwide, a limiting factor in the use of endoscopy is the lack of trained gastroenterologists. Research has shown that nonphysician clinicians (such as nurses) with specific training can ...

Two local healthcare organizations have joined forces to provide a new center for digestive health services. Carle Health and ...

Please provide your email address to receive an email when new articles are posted on . GLP-1RA use prior to upper endoscopy correlated with a higher rate of retained gastric content (OR = 5.56).

Please provide your email address to receive an email when new articles are posted on . Web-based patient education effectively decreased the need for upper gastrointestinal tract endoscopy in ...

Use upper endoscopy wisely Inappropriate endoscopy use generates unnecessary costs and exposes patients to harms without improving outcomes. Although upper endoscopy is commonly used in the diagnosis ...

Response and remission rates to immunosuppressive therapy was similar in Crohn disease (CD) with upper gastrointestinal (GI) involvement or extensive CD (ECD), according to study ...